Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2006-06-13
2006-06-13
Woitach, Joseph (Department: 1633)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C424S121000, C428S402200, C440S012610
Reexamination Certificate
active
07060689
ABSTRACT:
The present invention is directed to delivery and retention of active agents to targeted lymph nodes in a mammal using a ligand/anti-ligand pair. More particularly, the invention involves methods, compositions, and kits for delivery and retention of active agents to targeted lymph nodes using compositions comprising a ligand-colloid moiety and compositions comprising an anti-ligand. Active agents may be associated with one or more of the colloid, ligand, or anti-ligand. Conjugation of the ligand and anti-ligand after administration permits retention of aggregated colloid complex in targeted lymph nodes.
REFERENCES:
patent: 4310505 (1982-01-01), Baldeschwieler et al.
patent: 4789736 (1988-12-01), Canning et al.
patent: 4863713 (1989-09-01), Goodwin et al.
patent: 4904479 (1990-02-01), Illum
patent: 4948590 (1990-08-01), Hawrot et al.
patent: 5120526 (1992-06-01), Fritzberg et al.
patent: 5143713 (1992-09-01), Phillips et al.
patent: 5420105 (1995-05-01), Gustavson et al.
patent: 5482698 (1996-01-01), Griffiths
patent: 5527528 (1996-06-01), Allen et al.
patent: 5601800 (1997-02-01), Katti et al.
patent: 5690907 (1997-11-01), Lanza et al.
patent: 5698405 (1997-12-01), Goldenberg
patent: 5716594 (1998-02-01), Elmaleh et al.
patent: 5736119 (1998-04-01), Goldenberg et al.
patent: 5776094 (1998-07-01), Goldenberg
patent: 5792475 (1998-08-01), Davis et al.
patent: 6271209 (2001-08-01), Smith et al.
patent: 6521211 (2003-02-01), Unger et al.
patent: 2002/0187141 (2002-12-01), Goldenberg
Oussoren et al. Liposomes to target lymphatics by subcutaneous administration. 2001. Advanced Drug Delivery Reviews, 50, pp. 143-156.
Alving, “Liposomes as carriers of antigens and adjuvants,”J. Immuno Methods, 140:1-13, 1991.
Barth et al., “Boron neutron capture therapy of cancer,”Cancer Res., 50:1061-1070, 1990.
Bayer and Wilchek, “Avidin- and Streptavidin-containing probes,”Methods in Enzymology, 184:174-187, 1990.
Bookman, “Biologic therapies for gynecologic cancer,”Curr. Opin. Oncol., 7(5):478-484, 1995.
Chinol et al., “Biochemical modifications of avidin improve pharmacokinetics and biodistribution, and reduce immunogenicity,”Brit. J. Cancer, 78(2):189-197, 1998.
Coleman, “Chemical sensitizers and protectors,”Int. J. Radiation Onc. Biol. Phys., 42(4):781-783, 1998.
Corely et al., “Binding of biotinated-liposomes to streptavidin is influenced by liposome composition,”Biochim. Biophsy Acta, 1195:149-156, 1994.
Cox et al., “Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer,”Ann. Surg., 227(5):645-653, 1998.
Daemen et al., “Liposomes and virosomes as immunoadjuvant and antigen-carrier systems in vaccine formulations,” In:Medical Applications of Liposomes, Lasic and Papahadjopoulos (eds), Elsevier Science B.V., 117-143, 1998.
DeCicco et al., “Lymphoscintigarphy and radioguided biopsy of the sentinel axillary node in breast cancer,”J. Nucl. Med., 39(12):2080-2084, 1998.
DeFrees et al., “Sialyl Lewis X liposomes as a mulivalent ligand and inhibitor of E-selectin mediated cellular adhesion,”J. Am. Chem. Soc., 118:6101-6104, 1996.
DeVita et al., “Principles of cancer management: cancer genetics,” In:Cancer: Principles and Practice of Oncology, 5thed., J.B. Lippincott Co., Philadelphia, PA, Chapter 14: 285-293, 1997.
Gabizon et al., “Targeting folate receptor with folate linked to extremities of Poly(ethylene glycol)-grafted liposomes: in vitro studies,”Bioconjugate Chem., 10:289-298, 1999.
Goodman et al.,The Pharmacological Basis of Therapeutics, Gilman et al. (eds), Macmillan Publishing Co., New York, 1985.
Goodwin et al., “Pre-targeted immunoscintigraphy of murine tumors with indium-111-labeled bifunctional haptens,”J. Nucl. Med., 29(2):226-234, 1988.
Gregoriadis et al., “DNA vaccination: a role for liposomes,” In:Medical Applications of Liposomes, Lasic and Papahadjopoulos (eds), Elsevier Science B. V., 61-73, 1998.
Gregoriadis, “Liposomes as immunological adjuvants,”The Theory and Practical Application of Adjuvants, 7:145-169, 1995.
Griffiths et al., “Direct radiolabeling of monoclonal antibodies with generator-produced Rhenium-188 for radioimmunotherapy: labeling and animal biodistribution studies,”Cancer Res., 51(17):4594-4602, 1991.
Hader et al., “Sentinel lymph node biopsy using lymphoscintigraphy,”AORN J., 68:572-588, 1998.
Heeremans et al., “Fibrin binding of plasminogen coated liposomes in vitro,”Thromb Haemost., 75(1):134-139, 1996.
Hermanson, “Preparation of antibody—liposome conjugates,” In:Bioconjugate Techniques, Academic Press, San Diego, CA, p. 552-553, 1996.
Hermanson, “Use of glycolipids and lectins to effect specific conjugations,” In:Bioconjugate Techniques, Academic Press, San Diego, CA, p. 548-549, 1996.
Hirnle, “Liposomes for drug targeting in the lymphatic system,”Hybridoma, 16(1):127-132, 1997.
Hnatowich et al., “Improved tumor localization with (strept)avidin and labled biotin as a substitute for anitbody,”Nucl. Med. Biol., 20:189-195, 1993.
Hnatowich et al., “Investigations of avidin and biotin for imaging applications,”J. Nucl. Med., 28(8):1294-1302, 1987.
Hope et al., “Production of large unilamellar vesicles by a rapid extrusion procedures. Characterization of size distribution, trapped volume and ability to maintain a membrane potential,”Biochim. Et Biophys. Acta, 812:55-65, 1985.
Jeong et al., “Avidin-biotin system for targeting metastases: basic aspects,” In:Handbook of Targeted Delivery of Imaging Agents, Chapter 18:305-319, CRC Press, 1995.
Johnsson et al., “Optimization of drug loading procedures and characterization of liposomal formulations of two novel agents intended for boron neutron capture therapy (BNCT),”J. Liposome Res., 9(1):53-79, 1999.
Kalofonos et al. “Imaging of tumor in patients with indium-111-labeled biotin and streptavidin-conjugated antibodies: preliminary communication,”J. Nucl. Med., 31(11):1791-1796, 1990.
Kang and Pardridge, “Use of neutral avidin improves pharmacokinetics and brain delivery of biotin bound to an avidin-monoclonal antibody conjugate,”J. Pharm. Experimental Therapeutics, 269:344-350, 1994.
Klibanov et al., “Blood clearance of radiolabled antibody: enhancement by lactosamination and treatment with biotin-avidin or anti-mouse IgG antibodies,”J. Nucl. Med., 29(12):1951-1956, 1988.
Klibanov, “Targeted delivery of gas-filled microspheres, contrast agents for ultrasound imaging,”Adv. Drug Delivery Rev., 37:139-157, 1999.
Kohno et al., “Drug delivery systems for infection: liposome-incorporating antimicrobial drugs,”J. Infect Chemother., 4:159-173, 1998.
Komura et al., “Thermal neutron capture therapy of malignant melanoma using 10B-monoclonal antibodies: in vitro and in vivo analysis,”Melanoma Res., 1(5-6):397-403, 1991.
Kotz, “Advancing medical care: the role of nuclear medicine in radioguided surgery,”J. Nucl. Med., 39(12):13N-21N, 1998.
Krag et al., “Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe,”Surg. Oncol., 2:335-339, 1993.
Krag et al., “The sentinel node in breast cancer—a multicenter validation study,”N. Engl. J. Med., 339(14):941-946, 1998.
Krause, “Delivery of diagnostic agents in computed tomography,”Adv. Drug Delivery Rev., 37:159-173, 1999.
Kung et al., “Antibody-bering liposomes improve agglutination of latex particles used in clinical diagnostic assays,”Biochim. Biophys. Acta, 839:105-109, 1985.
Lasic and Pearlman, “Liposomes and lipidic particles in gene therapy,” In:Vesicles, Marcel Dekker, New York, 477-489, 1996.
Leserman et al., “Ligand targeting of liposomes,&#x
Goins Beth A.
Phillips William T.
Fulbright & Jaworski L.L.P.
Kelly Robert M.
The Board of Regents of the University of Texas System
Woitach Joseph
LandOfFree
Methods and compositions for delivery and retention of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and compositions for delivery and retention of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for delivery and retention of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3617994